These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20435447)

  • 41. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preliminary data concerning the reliability and psychometric properties of the Greek translation of the 20-item Subjective Well-Being Under Neuroleptic Treatment Scale (SWN-20).
    Siamouli M; Moutou K; Pantoula E; Magiria S; Chatzivasileiou I; Arapidis K; Chatzivasileiou A; Deres S; Fountoulakis KN
    Ann Gen Psychiatry; 2009 Jan; 8():3. PubMed ID: 19159480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome of suicidal patients with schizophrenia: results from a naturalistic study.
    Schennach-Wolff R; Jäger M; Seemüller F; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ; Riedel M
    Acta Psychiatr Scand; 2010 May; 121(5):359-70. PubMed ID: 19878135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study.
    Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Degner D; Buchkremer G; Gastpar M; Möller HJ; Riedel M
    Eur Psychiatry; 2009 Dec; 24(8):501-6. PubMed ID: 19559572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia.
    Karow A; Moritz S; Lambert M; Schöttle D; Naber D;
    Eur Psychiatry; 2012 Aug; 27(6):401-5. PubMed ID: 21570262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes.
    Dunayevich E; Sethuraman G; Enerson M; Taylor CC; Lin D
    Schizophr Res; 2006 Sep; 86(1-3):300-8. PubMed ID: 16860974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical correlates of objective and subjective quality of life among middle-aged and elderly female inpatients with chronic schizophrenia.
    Nakagawa S; Hayashi N
    Asian J Psychiatr; 2013 Oct; 6(5):389-93. PubMed ID: 24011685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
    Tollefson GD; Andersen SW
    J Clin Psychiatry; 1999; 60 Suppl 5():23-9; discussion 30. PubMed ID: 10192404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment.
    Lambert M; De Marinis T; Pfeil J; Naber D; Schreiner A
    Eur Psychiatry; 2010 May; 25(4):220-9. PubMed ID: 19926263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder.
    Schennach R; Meyer S; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ; Riedel M
    Eur Psychiatry; 2012 Nov; 27(8):625-33. PubMed ID: 22542652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The association of psychopathology with concurrent level of functioning and subjective well-being in persons with schizophrenia spectrum disorders.
    Hochstrasser L; Borgwardt S; Lambert M; Schimmelmann BG; Lang UE; Stieglitz RD; Huber CG
    Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):455-459. PubMed ID: 28357563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models.
    Lambert M; Schimmelmann BG; Schacht A; Suarez D; Haro JM; Novick D; Wagner T; Wehmeier PM; Huber CG; Hundemer HP; Dittmann RW; Naber D
    J Clin Psychopharmacol; 2011 Apr; 31(2):226-30. PubMed ID: 21346606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Remission, prediction and stability of symptoms in schizophrenia: A naturalistic 12-month follow-up study.
    Wolter A; Wolfgang Preuss U; Richard Krischke N; Mooi Wong W; Zimmermann J
    Int J Psychiatry Clin Pract; 2010 Sep; 14(3):160-7. PubMed ID: 24917315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subjective wellbeing under quetiapine treatment: effect of diagnosis, mood state, and anxiety.
    Lambert M; Naber D; Karow A; Huber CG; Köhler J; Heymann J; Schimmelmann BG
    Schizophr Res; 2009 May; 110(1-3):72-9. PubMed ID: 19321310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between symptomatic remission and functional outcome in first-episode schizophrenia.
    Bodén R; Sundström J; Lindström E; Lindström L
    Schizophr Res; 2009 Feb; 107(2-3):232-7. PubMed ID: 18957275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Social functioning and quality of life in schizophrenia patients --relationship with symptomatic remission and duration of illness].
    Górna K; Jaracz K; Jaracz J; Kiejda J; Grabowska-Fudala B; Rybakowski J
    Psychiatr Pol; 2014; 48(2):277-88. PubMed ID: 25016765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The subjective well-being under neuroleptic scale - short version (SWN-K) and the SF-36 health survey as quality of life measures in patients with schizophrenia.
    Mauriño J; Cordero L; Ballesteros J
    Patient Prefer Adherence; 2012; 6():83-5. PubMed ID: 22298947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia.
    Karow A; Czekalla J; Dittmann RW; Schacht A; Wagner T; Lambert M; Schimmelmann BG; Naber D
    J Clin Psychiatry; 2007 Jan; 68(1):75-80. PubMed ID: 17284133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative study on quality of life of patients of schizophrenia with and without depression.
    Dan A; Kumar S; Avasthi A; Grover S
    Psychiatry Res; 2011 Sep; 189(2):185-9. PubMed ID: 21453977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.